Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

Ukrainian Little Boy’s Life Saved with Bone Marrow Transplant at Hadassah


Zrichko with his parents

When four-and-a-half-year-old Zrichko Vladislav was diagnosed with osteopetrosis--a condition where the bones become overly dense and cause damage to nerves and tissues--his feet had already started to bend and he could hardly walk. A bone marrow transplant at the Hadassah University Medical Center saved his life.

When Zrichko's parents searched the internet and learned that a bone marrow transplant was a possible treatment, they began to explore opportunities within the Ukraine and neighboring Russia and then in other countries. For one reason or another, there were no viable options—until they explored Israel and Hadassah. Now, Zrichko's successful bone marrow transplant is behind him and his Hadassah doctors are closely monitoring his recovery.

"Until now we had to hold him on our hands all the time," says Lena, Zrichko's mother. "He could not go to the kindergarten because his immune system was too weak. His contacts with other children were limited to family relatives. We were afraid that he would be infected."

"We transfused Zrichko's entire blood with that of his donor's, and did the same thing with his immune system," says Dr. Paulina Stefansky, a senior physician in Hadassah's Department of Pediatric Hemato-Oncology, who is in charge of pediatric transplantations. Now Zrichko will receive rehabilitation treatment as his "new" immune system gains strength. While he will still have some bone-related problems--with his teeth, for example--he can look forward to a normal life.

Date: 6/15/2012


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America